Literature DB >> 2165102

Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections.

M K Breinig1, L A Kingsley, J A Armstrong, D J Freeman, M Ho.   

Abstract

Women attending family planning clinics in western Pennsylvania were enrolled into a prospective epidemiologic study of herpes simplex virus (HSV) infection. Detection of antibodies to HSV-1 and HSV-2 was based on an immunodot assay using type-specific glycoproteins gG-1 and gG-2. Serologic and historical data at enrollment were analyzed for 4527 subjects; the seroprevalence of HSV-2 was 21.6%. By multivariate analysis, HSV-2 infection as determined by seroprevalence was significantly and independently associated with age, years of sexual activity, race, one or more episodes of other genital infections, lower annual family income, and multiple sexual partners. The presence of antibody to HSV-1 was associated with a lower frequency of antibody to HSV-2, suggesting that developed immunity to HSV-1 protected against HSV-2 infection. Of 926 participants who had antibody to HSV-2, only 117 (12.6%) reported a history of genital herpes. Hence the vast majority of HSV-2 infections were inapparent. Although seroprevalence of HSV-2 was higher among black (35.4%) than white (18.5%) women, black women appeared to have significantly less symptomatic genital herpes than white women (7.7% vs. 14.7%, P less than .01).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165102     DOI: 10.1093/infdis/162.2.299

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Herpes simplex type 2 infection in a cohort aged 21 years.

Authors:  J Eberhart-Phillips; N P Dickson; C Paul; J P Fawcett; D Holland; J Taylor; A L Cunningham
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

3.  Measuring health-related quality of life in persons with genital herpes.

Authors:  D Wild; D Patrick; E Johnson; R Berzon; A Wald
Journal:  Qual Life Res       Date:  1995-12       Impact factor: 4.147

Review 4.  Laboratory techniques in the diagnosis of herpes simplex infection.

Authors:  R L Ashley
Journal:  Genitourin Med       Date:  1993-06

5.  The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic.

Authors:  J Heikel; S Sekkat; F Bouqdir; H Rich; B Takourt; F Radouani; N Hda; S Ibrahimy; A Benslimane
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

6.  Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.

Authors:  A L Cunningham; R Taylor; J Taylor; C Marks; J Shaw; A Mindel
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

7.  Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection.

Authors:  R Ashley; A Wald; L Corey
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Authors:  K Olson; P Macias; S Hutton; W A Ernst; G Fujii; J P Adler-Moore
Journal:  Vaccine       Date:  2009-10-14       Impact factor: 3.641

Review 9.  Genital herpes: review of the epidemic and potential use of type-specific serology.

Authors:  R L Ashley; A Wald
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

10.  Vagina dentata revisited: gender and asymptomatic shedding of genital herpes.

Authors:  K L Pliskin
Journal:  Cult Med Psychiatry       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.